EGFR/CDK2-IN-4 (compound 4c) is a dual inhibitor targeting EGFR and CDK-2, demonstrating IC50 values of 89.6 nM for EGFR and 165.4 nM for CDK-2. It prompts apoptosis in MCF-7 cells and causes S phase cell cycle arrest, exhibiting substantial anti-cancer
Molecular Weight:
468.55
Formula:
C24H16N6OS2
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted
